We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+8.98%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$642M
AUM Growth
+$15.3M
Cap. Flow
-$7.08M
Cap. Flow %
-1.1%
Top 10 Hldgs %
16.47%
Holding
446
New
35
Increased
51
Reduced
176
Closed
52

Top Buys

Rank Stock Value
1
CMBM
Cambium Networks
CMBM
+$7.44M
2
DRS icon
Leonardo DRS
DRS
+$4.65M
3
TPIC
TPI Composites
TPIC
+$3.57M
4
SEDG icon
SolarEdge
SEDG
+$3.54M
5
DLTR icon
Dollar Tree
DLTR
+$3.19M

Sector Composition

Rank Sector Weight
1 Technology 26.51%
2 Industrials 19.42%
3 Healthcare 14.72%
4 Materials 8.89%
5 Consumer Staples 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DCBO
151
Docebo
DCBO
$574M
$1.38M 0.21%
+41,584
New +$1.25M
BWXT icon
152
BWX Technologies
BWXT
$15.6B
$1.34M 0.21%
23,152
+20,877
+918% +$1.2M
FCX icon
153
Freeport-McMoran
FCX
$95.4B
$1.33M 0.21%
34,937
-509
-1% -$17.8K
SPWR
154
DELISTED
SunPower Corporation Common Stock
SPWR
$1.32M 0.21%
73,456
-743
-1% -$15.2K
GDXJ icon
155
VanEck Junior Gold Miners ETF
GDXJ
$8.36B
$1.31M 0.2%
36,788
+16,092
+78% +$530K
GDX icon
156
VanEck Gold Miners ETF
GDX
$27B
$1.3M 0.2%
45,421
+18,042
+66% +$482K
SPNE
157
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$1.3M 0.2%
+155,301
New +$1.05M
VMC icon
158
Vulcan Materials
VMC
$36.2B
$1.29M 0.2%
7,381
EVH icon
159
Evolent Health
EVH
$491M
$1.29M 0.2%
45,872
-461
-1% -$13.2K
AKYA
160
DELISTED
Akoya BioSciences
AKYA
$1.25M 0.2%
+130,988
New +$1.61M
RVNC
161
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.25M 0.2%
67,933
-689
-1% -$15.8K
WLDN icon
162
Willdan Group
WLDN
$1.29B
$1.24M 0.19%
69,674
+23,644
+51% +$364K
WFC icon
163
Wells Fargo
WFC
$268B
$1.23M 0.19%
29,886
-1,688
-5% -$74.7K
VLO icon
164
Valero Energy
VLO
$94.6B
$1.23M 0.19%
9,685
PDCE
165
DELISTED
PDC Energy, Inc.
PDCE
$1.23M 0.19%
19,330
-1,092
-5% -$76.2K
CTVA icon
166
Corteva
CTVA
$50.3B
$1.22M 0.19%
20,800
-10,460
-33% -$662K
INCY icon
167
Incyte
INCY
$24.4B
$1.22M 0.19%
+15,221
New +$1.16M
AMGN icon
168
Amgen
AMGN
$226B
$1.22M 0.19%
4,648
-262
-5% -$70.2K
SLGN icon
169
Silgan Holdings
SLGN
$4.43B
$1.22M 0.19%
23,508
-8,287
-26% -$406K
LDOS icon
170
Leidos
LDOS
$17.7B
$1.21M 0.19%
+11,545
New +$1.18M
CHPT icon
171
ChargePoint
CHPT
$165M
$1.21M 0.19%
6,362
+1,616
+34% +$393K
OOMA icon
172
Ooma
OOMA
$562M
$1.21M 0.19%
+88,927
New +$1.32M
CL icon
173
Colgate-Palmolive
CL
$74.4B
$1.19M 0.19%
15,150
SLB icon
174
SLB Ltd
SLB
$76.8B
$1.19M 0.19%
22,285
-14,104
-39% -$702K
NVDA icon
175
NVIDIA
NVDA
$5.47T
$1.18M 0.18%
+80,460
New +$1.18M

Similar funds

Essex Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, Essex Investment Management held 446 positions worth $642M, up 2.4% from $627M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Essex Investment Management's Q4 2022 filing shows 35 new, 51 increased, 176 reduced and 52 closed positions. Its largest new stake was Cambium Networks: 368,927 shares worth $8M. The largest sale was Ford, an estimated $4.51M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Industrials and Healthcare.

  • Essex Investment Management's largest Q4 2022 buy was Cambium Networks: 368,927 shares worth $8M.
  • Essex Investment Management added most to SolarEdge in Q4 2022, an estimated $3.54M increase.
  • Essex Investment Management's biggest Q4 2022 reduction was Ford, cutting an estimated $4.51M.
  • Essex Investment Management fully exited Rada Electronic Industries Ltd in Q4 2022, selling an estimated $3.92M.
  • Essex Investment Management's ten largest holdings make up 16% of its $642M portfolio in Q4 2022.
  • Essex Investment Management opened 35 new positions and closed 52 in Q4 2022.
  • Essex Investment Management's portfolio value rose 2.4% quarter-over-quarter to $642M.

Based on Essex Investment Management's 13F filing for Q4 2022, filed 3 Feb 2023.